Matrixyl (Palmitoyl Pentapeptide): Research & Evidence

Matrixyl is the most extensively studied cosmetic peptide, with 10+ RCTs involving 1,000+ subjects. A 2018 systematic review found moderate efficacy (10-30% wrinkle reduction vs baseline) across published trials. The compound stimulates collagen synthesis through MAPK/ERK signaling, though the precise receptor target remains unidentified. Key evidence limitations include frequent industry funding, variable blinding quality, and unresolved questions about actual skin penetration depth. The Cosmetic Ingredient Review determined it safe as used (2007), and the EU SCCS found no safety concerns at concentrations up to 10%.